Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 19)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
8-Feb-10PriceTarget Research, Inc.N/AMEDTOX has a current Overall Rating of C (Neutral).7$25  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: MEDTOX SCIENTIF -- MTOX1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: AMRI , BRLI , ERES , MTOX , NADX , NHWK , RDNT -- MEDICAL SERVICES3$4  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for MTOX: the economy's impact on MTOX's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Medtox Scientific, Inc.41$65  View Abstract
Next 9

Independent Reports (Showing 1 to 10 of 19)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
8-Feb-10PriceTarget Research, Inc.N/AMEDTOX has a current Overall Rating of C (Neutral).7$25View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: MEDTOX SCIENTIF -- MTOX1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: AMRI , BRLI , ERES , MTOX , NADX , NHWK , RDNT -- MEDICAL SERVICES3$4View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for MTOX: the economy's impact on MTOX's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10Wright ReportsN/AWright Investors Service Comprehensive Report for Medtox Scientific, Inc.41$65View Abstract
Next 9

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.